市場調査レポート

商品コード

1383633

緊急避妊薬市場- 世界の産業規模、動向、機会、予測、2018年～2028年、タイプ別、流通チャネル別、地域別

Emergency Contraceptive Pills Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Type, by Distribution Channel, by region, and Competition

出版日: 2023年10月03日 | 発行: TechSci Research

| ページ情報: 英文 190 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

Unprintable PDF (Single User License)

USD 4,900 778,953円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷はできません。

PDF and Excel (Multi-User License)

USD 5,900 937,923円

レポートPDFおよびExcelデータシートを企業内でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。レポート内のデータを含むExcelが併せて納品されます。Excelはライセンスを付与された企業の社内でのご利用が可能です。PDF内コンテンツの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF and Excel (Custom Research License)

USD 8,900 1,414,833円

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=158.97円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

全表示
概要
目次

概要

サンプル依頼リストに入れる

緊急避妊薬の世界市場は、2022年に5億4,560万米ドルと評価され、2028年までのCAGRは4.43%で、予測期間中に目覚ましい成長を遂げると予測されています。

緊急避妊ピル（ECP）は、しばしば「モーニングアフターピル」または「デイアフターピル」と呼ばれ、妊娠を防ぐために使用される避妊の一形態です。これらのピルは、避妊していない性交渉の後、できるだけ早く服用するように設計されており、定期的または継続的な避妊を目的としたものではありません。ECPの主な目的は、通常の避妊法に失敗した場合、避妊法を使用しなかった場合、または使用法を誤った場合に妊娠のリスクを減らすことです。ECPは、成立した妊娠を終了させるためのものではなく、中絶の一形態でもありません。ECPは、無防備な性交渉の後、できるだけ早く服用するのが最も効果的です。そのため、速やかに服用することが重要です。ECPの中には、無防備な性交渉後72時間（3日間）まで有効なものもあれば、120時間（5日間）まで有効なものもあります。ECPは一般的にほとんどの人にとって安全であり、長期的な健康リスクはないと考えられています。しかし、他の薬と同様に、吐き気、嘔吐、乳房の圧痛、疲労感、月経パターンの変化などの副作用の可能性があります。

主な要因のひとつは、避妊に対するアンメットニーズです。多くの人は、定期的な避妊法を利用できなかったり、一貫して利用できなかったりするため、緊急避妊オプションに対する需要が高まっています。公衆啓発キャンペーン、教育イニシアティブ、性教育の向上は、緊急避妊に対する理解を深め、使用の増加につながっています。避妊の失敗、避妊へのアクセス不足、またはその他の理由による無防備な性交渉の蔓延が、緊急避妊の需要を後押ししています。多くの国では、処方箋なしで緊急避妊ピルを入手できるようになったことで、緊急避妊ピルがより身近になり、消費者の需要を促進しています。都市化の進展やキャリア目標の重視など、ライフスタイルの変化は、緊急避妊が必要とされる状況につながる可能性があります。性感染症（STD）に対する懸念は、無防備なセックスの後の予防措置として緊急避妊薬の使用拡大につながる可能性があります。

市場概要
予測期間	2024-2028
市場規模	5億4,560万米ドル
2028年の市場規模	7億522万米ドル
CAGR 2023-2028	4.43%
急成長セグメント	オンラインストア
最大市場	北米

Afaxys Pharma LLC
- Business Overview
- Company Snapshot
- Products & Services
- Financials（In case of listed companies）
- Recent Developments
- SWOT Analysis
Bayer AG
- Business Overview
- Company Snapshot
- Products & Services
- Financials（In case of listed companies）
- Recent Developments
- SWOT Analysis
Combe Inc.
- Business Overview
- Company Snapshot
- Products & Services
- Financials（In case of listed companies）
- Recent Developments
- SWOT Analysis
Foundation Consumer Healthcare LLC
- Business Overview
- Company Snapshot
- Products & Services
- Financials（In case of listed companies）
- Recent Developments
- SWOT Analysis
Gedeon Richter Plc
- Business Overview
- Company Snapshot
- Products & Services
- Financials（In case of listed companies）
- Recent Developments
- SWOT Analysis
HLL Lifecare Ltd.
- Business Overview
- Company Snapshot
- Products & Services
- Financials（In case of listed companies）
- Recent Developments
- SWOT Analysis
Knoll Healthcare Pvt. Ltd.
- Business Overview
- Company Snapshot
- Products & Services
- Financials（In case of listed companies）
- Recent Developments
- SWOT Analysis
Laboratoire HRA Pharma SAS
- Business Overview
- Company Snapshot
- Products & Services
- Financials（In case of listed companies）
- Recent Developments
- SWOT Analysis
Lupin Ltd.
- Business Overview
- Company Snapshot
- Products & Services
- Financials（In case of listed companies）
- Recent Developments
- SWOT Analysis
Mankind Pharma Ltd.
- Business Overview
- Company Snapshot
- Products & Services
- Financials（In case of listed companies）
- Recent Developments
- SWOT Analysis

第17章戦略的提言

第18章調査会社・免責事項

Product Code: 17476

Global Emergency Contraceptive Pills Market has valued at USD 545.60 million in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 4.43% through 2028. Emergency Contraceptive Pills (ECPs), often referred to as "morning-after pills" or day-after pills, are a form of contraception used to prevent pregnancy after unprotected sexual intercourse or contraceptive failure. These pills are designed to be taken as soon as possible after unprotected sex and are not intended for regular or ongoing contraception. The primary purpose of ECPs is to reduce the risk of pregnancy when regular contraception methods fail, are not used, or were used incorrectly. They are not intended to terminate an established pregnancy, and they are not a form of abortion. ECPs are most effective when taken as soon as possible after unprotected sex. Their effectiveness decreases with time, so it's important to take them promptly. Some ECPs are effective up to 72 hours (3 days) after unprotected sex, while others may have a longer window of effectiveness, such as up to 120 hours (5 days). ECPs are generally considered safe for most people and are not associated with long-term health risks. However, like all medications, they may have potential side effects, which can include nausea, vomiting, breast tenderness, fatigue, and changes in menstrual patterns.

One of the primary drivers is the unmet need for contraception. Many individuals may not have access to or use regular contraception methods consistently, leading to a demand for emergency contraceptive options. Public awareness campaigns, educational initiatives, and improved sex education have contributed to a better understanding of emergency contraception, leading to increased use. The prevalence of unprotected sexual intercourse, whether due to contraceptive failure, lack of access to contraception, or other reasons, drives the demand for emergency contraception. In many countries, the availability of emergency contraceptive pills without a prescription has made them more accessible and has driven consumer demand. Changing lifestyles, including increased urbanization and a greater emphasis on career goals, can lead to situations where emergency contraception is needed. Concerns about sexually transmitted diseases (STDs) can lead to greater use of emergency contraception as a preventive measure after unprotected sex.

Key Market Drivers

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 545.60 Million
Market Size 2028	USD 705.22 Million
CAGR 2023-2028	4.43%
Fastest Growing Segment	Online Stores
Largest Market	North America

High Incidence of Unprotected Sex

Emergency contraceptive pills are specifically designed to prevent unintended pregnancies when regular contraception methods have failed, were not used, or were used incorrectly. Unprotected sex carries a higher risk of pregnancy, and ECPs provide a timely and effective option to reduce this risk. Unprotected sex can result from a variety of circumstances, including contraceptive method failure (e.g., condom breakage), lack of access to contraception, sexual assault, or unexpected sexual encounters. In these emergency situations, individuals may turn to ECPs to prevent an unintended pregnancy. ECPs offer a level of privacy and discretion, allowing individuals to take control of their reproductive health without the need for a healthcare provider's involvement or the disclosure of personal information.

The effectiveness of ECPs decreases with time after unprotected sex. Therefore, individuals who engage in unprotected sex and want to prevent pregnancy are often motivated to obtain and use ECPs as soon as possible, making timeliness a crucial factor.In some cases, individuals may not have access to regular contraception methods, such as birth control pills or condoms. In these situations, ECPs can serve as a backup option to prevent pregnancy. Increasing awareness and education about emergency contraception have led to more people recognizing the availability and benefits of ECPs, which can drive demand. Changing lifestyles, including increased social activities and relationships, may lead to situations where individuals find themselves engaging in unprotected sex unexpectedly. Even when regular contraception methods are used correctly, there is always a small risk of failure. This concern can motivate individuals to use ECPs as an added precaution. In many countries, ECPs are legally available and may be accessible without a prescription. These regulatory factors can contribute to the demand for ECPs in cases of unprotected sex. For individuals who experience anxiety or worry after unprotected sex, the availability of ECPs can provide psychological relief and peace of mind. This factor will help in the development of the Global Emergency Contraceptive Pills Market.

Increasing Unmet Need for Contraception

Many individuals and couples may not consistently use regular contraception methods, such as birth control pills, condoms, or intrauterine devices (IUDs). This inconsistent or non-use of contraception methods can lead to a higher risk of unintended pregnancies. Even when individuals do use regular contraception methods, there is always a small risk of failure. Condoms can break, birth control pills may be missed, and other methods may not work as intended. In such cases, individuals may seek ECPs as a backup option to prevent pregnancy. Some individuals may have limited access to reliable contraception methods due to factors such as geographical barriers, cost constraints, lack of healthcare access, or cultural and social barriers. ECPs can serve as a readily available option for those facing barriers to regular contraception. Unplanned or unexpected sexual encounters, sexual assault, or instances where contraception was not readily available can create emergency situations where individuals turn to ECPs to prevent an unintended pregnancy. ECPs offer a level of privacy and discretion, allowing individuals to take control of their reproductive health without the need for a healthcare provider's involvement or the disclosure of personal information.

The effectiveness of ECPs decreases with time after unprotected sex. In cases where regular contraception was not used or failed, individuals may use ECPs promptly to reduce the risk of pregnancy. Increasing awareness and education about emergency contraception can lead to more people recognizing the availability and benefits of ECPs, which can drive demand among those with unmet contraception needs. Changing lifestyles, including increased social activities and relationships, may lead to situations where individuals engage in sexual activity unexpectedly, without access to regular contraception. Even when regular contraception methods are used correctly, there is always a small risk of failure. This concern can motivate individuals to use ECPs as an added precaution when they believe there is an unmet need for contraception. In many countries, ECPs are legally available and may be accessible without a prescription. These regulatory factors can contribute to the demand for ECPs in cases where individuals have unmet contraception needs. For individuals who experience anxiety or worry about the possibility of an unintended pregnancy due to an unmet contraception need, the availability of ECPs can provide psychological relief and peace of mind. This factor will pace up the demand of the Global Emergency Contraceptive Pills Market.

Rising Awareness Emergency Contraception

As awareness of emergency contraception spreads, more individuals become aware of the availability of ECPs as a contraceptive option. This knowledge is critical because many people may not have been aware of ECPs as an option in the past. Education and awareness campaigns often include information on how ECPs work to prevent pregnancy. When individuals understand the mechanism of action and the importance of taking ECPs within a certain time frame after unprotected sex, they are more likely to seek and use these pills when needed. Awareness efforts emphasize the time sensitivity of ECPs. People are made aware that these pills are most effective when taken as soon as possible after unprotected intercourse, which can motivate them to seek them promptly.

Increasing awareness campaigns can help dispel myths and misinformation about emergency contraception, leading to more accurate knowledge among potential users. Awareness campaigns often promote safe and responsible sexual behavior, including the use of regular contraception methods. However, they also highlight ECPs as a backup option in case of contraceptive failure or unprotected sex. Awareness efforts can help reduce the stigma associated with emergency contraception, making it more socially acceptable to seek and use ECPs when necessary. Increasing awareness often extends to healthcare providers who can then educate their patients about emergency contraception. When healthcare professionals are well-informed, they can provide accurate information and guidance to patients. Awareness campaigns may coincide with efforts to improve access to ECPs, making them more readily available to consumers. Increased access can drive demand. Awareness empowers individuals to take control of their reproductive health by making informed decisions about contraception, including the use of ECPs when necessary. Public health initiatives often include awareness campaigns about sexual health and contraception, which can lead to increased awareness and use of ECPs as part of comprehensive family planning strategies. Advertising campaigns by pharmaceutical companies and healthcare organizations can play a significant role in raising awareness about ECPs. This factor will accelerate the demand of the Global Emergency Contraceptive Pills Market.

Key Market Challenges

Stigma and Misinformation

Stigma associated with emergency contraception can discourage individuals from seeking or using these pills. This stigma may arise from cultural, religious, or social beliefs that view emergency contraception as morally or socially unacceptable. There is often misinformation and myths surrounding emergency contraceptive pills, which can create confusion and hesitation among potential users. Common myths include misconceptions about their safety, effectiveness, and side effects. Stigma and misinformation can create barriers to accessing emergency contraception. For example, individuals may avoid seeking ECPs from healthcare providers or pharmacies due to fear of judgment or misunderstanding about how the pills work. Misinformation can contribute to a lack of awareness about emergency contraception. Some individuals may not even be aware that ECPs are available or how they can be obtained. The fear of being judged by healthcare providers, pharmacists, or peers can deter individuals from seeking emergency contraception. This fear may be based on the belief that using ECPs implies irresponsible behavior or promiscuity. Cultural and religious beliefs can strongly influence attitudes towards contraception, including emergency contraception. Some cultures and religious groups may consider the use of ECPs as morally unacceptable. Inadequate sexual education can contribute to misinformation about emergency contraception. Comprehensive sex education programs are essential in addressing this challenge and providing accurate information. Misinformation can lead to misconceptions about the side effects of emergency contraception, causing unnecessary concerns or fears about health risks.

Access and Equity

Access to healthcare services, including ECPs, can vary significantly by region. Rural areas and underserved communities may have limited access to pharmacies or healthcare providers, making it difficult for individuals in these areas to obtain ECPs promptly. The cost of ECPs can be a barrier to access for many individuals, especially in low-income or resource-constrained settings. Even when ECPs are available, their price can make them inaccessible to those with limited financial resources. In some regions, the healthcare infrastructure may be underdeveloped, leading to challenges in distribution and accessibility of ECPs. Limited availability of pharmacies, clinics, or trained healthcare providers can hinder access. Cultural norms, social attitudes, and stigma related to sexual and reproductive health can create barriers to accessing ECPs. In some cultures, discussing or seeking contraception may be discouraged or considered taboo. Individuals may be unaware of the existence of ECPs or how to obtain them, leading to underutilization even when they are available. In some regions, regulatory restrictions, age limits, or prescription requirements can limit access to ECPs. Changes in these regulations may be necessary to improve access and equity. In some cases, healthcare providers or pharmacists may have personal or religious objections to providing ECPs, leading to challenges in access for patients. Ensuring that adolescents have equitable access to ECPs is a particular concern, as they may face unique barriers related to consent, privacy, and stigma. Advocacy for lower prices and increased affordability of ECPs, particularly in low- and middle-income countries.

Key Market Trends

Telemedicine and E-Commerce

Telemedicine platforms have been providing individuals with the opportunity to consult with healthcare professionals remotely. This includes discussing their need for emergency contraception, receiving guidance on its use, and obtaining prescriptions when necessary. Telemedicine services have made it easier for individuals to access medical advice and prescriptions for emergency contraceptive pills from the comfort and privacy of their homes. Online retailers and e-commerce platforms have been offering emergency contraceptive pills for sale. This allows individuals to purchase these products discreetly and conveniently without visiting a physical pharmacy or healthcare provider. E-commerce platforms have expanded access to emergency contraception, especially for those who may feel uncomfortable or embarrassed discussing the topic in person. Depending on the region and local regulations, some e-commerce platforms may offer both prescription and non-prescription (over the counter) emergency contraceptive pills. This provides consumers with choices based on their specific needs and circumstances. Telemedicine and e-commerce provide a level of privacy and convenience that many individuals find appealing. They can access emergency contraception without face-to-face interactions and without disclosing their personal information to pharmacy staff or healthcare providers. Through telemedicine, individuals can engage in digital consultations with healthcare professionals who can assess their situation, provide guidance, and prescribe emergency contraception if deemed appropriate. This process may include video calls, chat services, or secure messaging. Telemedicine and e-commerce have the potential to expand access to emergency contraception to underserved areas or regions with limited access to healthcare facilities or pharmacies.

Segmental Insights

Type Insights

In 2022, the Global Emergency Contraceptive Pills Market largest share was held by Combination Pills segment and is predicted to continue expanding over the coming years. Combination emergency contraceptive pills, which typically contain both progestin and estrogen hormones, are considered highly effective in preventing pregnancy when taken as directed. This effectiveness can make them a preferred choice for many consumers. Some combination pills have a longer window of efficacy compared to other forms of emergency contraception. This means they can be taken up to 72 hours or even 120 hours (depending on the specific product) after unprotected intercourse, providing a wider time frame for effectiveness. In some regions, combination emergency contraceptive pills are available both by prescription and over the counter (OTC). OTC availability enhances accessibility and convenience for consumers. Healthcare providers may recommend combination pills based on an individual's medical history and needs. This recommendation from healthcare professionals can drive the demand for combination emergency contraception.

Distribution Channel Insights

In 2022, the Global Emergency Contraceptive Pills Market largest share was held by Retail Stores segment in the forecast period and is predicted to continue expanding over the coming years. Retail stores, such as pharmacies and drugstores, are widely accessible to consumers in many regions. This accessibility makes it convenient for individuals to purchase emergency contraceptive pills when needed, often without the need for an appointment or prescription. In several countries, emergency contraceptive pills are available over the counter (OTC) without the need for a prescription. Retail stores are well-suited to distribute OTC products, further enhancing their market share. Retail stores offer a level of privacy and discretion for consumers. Many people prefer to purchase emergency contraception in person rather than through other channels, as it allows them to maintain their privacy. Retail stores typically provide immediate access to emergency contraceptive pills. This quick availability can be crucial, as these pills are most effective when taken as soon as possible after unprotected intercourse. Pharmacists and healthcare professionals working in retail stores can provide valuable information and guidance to customers regarding the proper use of emergency contraception.

Regional Insights

The North America region dominates the Global Emergency Contraceptive Pills Market in 2022. North America, particularly the United States, has a large population and a high level of disposable income. This creates a substantial market for pharmaceutical products, including emergency contraceptive pills. The ability and willingness to pay for such products contribute to market dominance. The United States and Canada have regulatory environments that allow for relatively easy access to emergency contraceptive pills. In the United States, for example, emergency contraception has been available over the counter (OTC) without a prescription for some time, making it easily accessible to a broad range of consumers. North America boasts a well-developed healthcare infrastructure, including a network of pharmacies and healthcare providers. This infrastructure facilitates the distribution and accessibility of emergency contraceptive pills. There have been public health campaigns and educational efforts to raise awareness about emergency contraception in North America. These initiatives have contributed to increased knowledge and use of such products.

Key Market Players

Afaxys Pharma LLC

Bayer AG

Combe Inc.

Foundation Consumer Healthcare LLC

Gedeon Richter Plc

HLL Lifecare Ltd.

Knoll Healthcare Pvt. Ltd.

Laboratoire HRA Pharma SAS

Lupin Ltd.

Mankind Pharma Ltd.

Report Scope:

In this report, the Global Emergency Contraceptive Pills Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Emergency Contraceptive Pills Market, By Type:

Combination Pills
Progesterone Pills
Others

Emergency Contraceptive Pills Market, By Distribution Channel:

Retail Stores
Online Stores
Others

Global Emergency Contraceptive Pills Market, By region:

North America
United States
Canada
Mexico
Asia-Pacific
China
India
South Korea
Australia
Japan
Europe
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Emergency Contraceptive Pills Market.

Available Customizations:

Global Emergency Contraceptive Pills Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Emergency Contraceptive Pills Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (Combination Pills, Progesterone Pills, and Others)
- 5.2.2. By Distribution Channel (Retail Stores, Online Stores, and Others)
- 5.2.3. By Region
- 5.2.4. By Company (2022)
5.3. Market Map

6. Asia Pacific Emergency Contraceptive Pills Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Distribution Channel
- 6.2.3. By Country
6.3. Asia Pacific: Country Analysis
- 6.3.1. China Emergency Contraceptive Pills Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Distribution Channel
- 6.3.2. India Emergency Contraceptive Pills Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Distribution Channel
- 6.3.3. Australia Emergency Contraceptive Pills Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Distribution Channel
- 6.3.4. Japan Emergency Contraceptive Pills Market Outlook
  - 6.3.4.1. Market Size & Forecast
    - 6.3.4.1.1. By Value
  - 6.3.4.2. Market Share & Forecast
    - 6.3.4.2.1. By Type
    - 6.3.4.2.2. By Distribution Channel
- 6.3.5. South Korea Emergency Contraceptive Pills Market Outlook
  - 6.3.5.1. Market Size & Forecast
    - 6.3.5.1.1. By Value
  - 6.3.5.2. Market Share & Forecast
    - 6.3.5.2.1. By Type
    - 6.3.5.2.2. By Distribution Channel

7. Europe Emergency Contraceptive Pills Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Distribution Channel
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Emergency Contraceptive Pills Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Distribution Channel
- 7.3.2. Germany Emergency Contraceptive Pills Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Distribution Channel
- 7.3.3. Spain Emergency Contraceptive Pills Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Distribution Channel
- 7.3.4. Italy Emergency Contraceptive Pills Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Distribution Channel
- 7.3.5. United Kingdom Emergency Contraceptive Pills Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Distribution Channel

8. North America Emergency Contraceptive Pills Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Distribution Channel
- 8.2.3. By Country
8.3. North America: Country Analysis
- 8.3.1. United States Emergency Contraceptive Pills Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Distribution Channel
- 8.3.2. Mexico Emergency Contraceptive Pills Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Distribution Channel
- 8.3.3. Canada Emergency Contraceptive Pills Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Distribution Channel

9. South America Emergency Contraceptive Pills Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Distribution Channel
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Emergency Contraceptive Pills Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Distribution Channel
- 9.3.2. Argentina Emergency Contraceptive Pills Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Distribution Channel
- 9.3.3. Colombia Emergency Contraceptive Pills Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Emergency Contraceptive Pills Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Distribution Channel
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Emergency Contraceptive Pills Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Distribution Channel
- 10.3.2. Saudi Arabia Emergency Contraceptive Pills Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Distribution Channel
- 10.3.3. UAE Emergency Contraceptive Pills Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global Emergency Contraceptive Pills Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

16.1. Afaxys Pharma LLC
- 16.1.1. Business Overview
- 16.1.2. Company Snapshot
- 16.1.3. Products & Services
- 16.1.4. Financials (In case of listed companies)
- 16.1.5. Recent Developments
- 16.1.6. SWOT Analysis
16.2. Bayer AG
- 16.2.1. Business Overview
- 16.2.2. Company Snapshot
- 16.2.3. Products & Services
- 16.2.4. Financials (In case of listed companies)
- 16.2.5. Recent Developments
- 16.2.6. SWOT Analysis
16.3. Combe Inc.
- 16.3.1. Business Overview
- 16.3.2. Company Snapshot
- 16.3.3. Products & Services
- 16.3.4. Financials (In case of listed companies)
- 16.3.5. Recent Developments
- 16.3.6. SWOT Analysis
16.4. Foundation Consumer Healthcare LLC
- 16.4.1. Business Overview
- 16.4.2. Company Snapshot
- 16.4.3. Products & Services
- 16.4.4. Financials (In case of listed companies)
- 16.4.5. Recent Developments
- 16.4.6. SWOT Analysis
16.5. Gedeon Richter Plc
- 16.5.1. Business Overview
- 16.5.2. Company Snapshot
- 16.5.3. Products & Services
- 16.5.4. Financials (In case of listed companies)
- 16.5.5. Recent Developments
- 16.5.6. SWOT Analysis
16.6. HLL Lifecare Ltd.
- 16.6.1. Business Overview
- 16.6.2. Company Snapshot
- 16.6.3. Products & Services
- 16.6.4. Financials (In case of listed companies)
- 16.6.5. Recent Developments
- 16.6.6. SWOT Analysis
16.7. Knoll Healthcare Pvt. Ltd.
- 16.7.1. Business Overview
- 16.7.2. Company Snapshot
- 16.7.3. Products & Services
- 16.7.4. Financials (In case of listed companies)
- 16.7.5. Recent Developments
- 16.7.6. SWOT Analysis
16.8. Laboratoire HRA Pharma SAS
- 16.8.1. Business Overview
- 16.8.2. Company Snapshot
- 16.8.3. Products & Services
- 16.8.4. Financials (In case of listed companies)
- 16.8.5. Recent Developments
- 16.8.6. SWOT Analysis
16.9. Lupin Ltd.
- 16.9.1. Business Overview
- 16.9.2. Company Snapshot
- 16.9.3. Products & Services
- 16.9.4. Financials (In case of listed companies)
- 16.9.5. Recent Developments
- 16.9.6. SWOT Analysis
16.10. Mankind Pharma Ltd.
- 16.10.1. Business Overview
- 16.10.2. Company Snapshot
- 16.10.3. Products & Services
- 16.10.4. Financials (In case of listed companies)
- 16.10.5. Recent Developments
- 16.10.6. SWOT Analysis

緊急避妊薬市場- 世界の産業規模、動向、機会、予測、2018年～2028年、タイプ別、流通チャネル別、地域別

Emergency Contraceptive Pills Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Type, by Distribution Channel, by region, and Competition

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 緊急避妊薬の世界市場展望

第6章 アジア太平洋地域の緊急避妊薬市場展望

第7章 欧州の緊急避妊薬市場展望

第8章 北米の緊急避妊薬市場展望

第9章 南米の緊急避妊薬市場展望

第10章 中東・アフリカの緊急避妊薬市場展望

第11章 市場力学

第12章 市場動向と発展

第13章 緊急避妊薬の世界市場SWOT分析

第14章 ポーターのファイブフォース分析

第15章 PESTLE分析

第16章 競合情勢

第17章 戦略的提言

第18章 調査会社・免責事項

Key Market Players

Report Scope:

Emergency Contraceptive Pills Market, By Type:

Emergency Contraceptive Pills Market, By Distribution Channel:

Global Emergency Contraceptive Pills Market, By region:

Competitive Landscape

Available Customizations:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Emergency Contraceptive Pills Market Outlook

6. Asia Pacific Emergency Contraceptive Pills Market Outlook

7. Europe Emergency Contraceptive Pills Market Outlook

8. North America Emergency Contraceptive Pills Market Outlook

9. South America Emergency Contraceptive Pills Market Outlook

10. Middle East and Africa Emergency Contraceptive Pills Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Emergency Contraceptive Pills Market: SWOT Analysis

14. Porter's Five Forces Analysis

15. PESTLE Analysis

16. Competitive Landscape

17. Strategic Recommendations

18. About Us & Disclaimer

第1章概要

第2章調査手法

第3章エグゼクティブサマリー

第4章顧客の声

第5章緊急避妊薬の世界市場展望

第6章アジア太平洋地域の緊急避妊薬市場展望

第7章欧州の緊急避妊薬市場展望

第8章北米の緊急避妊薬市場展望

第9章南米の緊急避妊薬市場展望

第10章中東・アフリカの緊急避妊薬市場展望

第11章市場力学

第12章市場動向と発展

第13章緊急避妊薬の世界市場SWOT分析

第14章ポーターのファイブフォース分析

第16章競合情勢

第17章戦略的提言

第18章調査会社・免責事項